MAPS VACCINE Trademark

Trademark Overview

On Friday, January 25, 2019, a trademark application was filed for MAPS VACCINE with the United States Patent and Trademark Office. The USPTO has given the MAPS VACCINE trademark a serial number of 88276606. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 8, 2024. This trademark is owned by Affinivax, Inc.. The MAPS VACCINE trademark is filed in the Pharmaceutical Products category with the following description:

vaccines; vaccines for the prophylaxis and treatment of infectious diseases and cancer; vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; vaccines comprising polysaccharide antigens and protein-based antigens; vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens
maps vaccine

General Information

Serial Number88276606
Word MarkMAPS VACCINE
Filing DateFriday, January 25, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2021

Trademark Statements

Goods and Servicesvaccines; vaccines for the prophylaxis and treatment of infectious diseases and cancer; vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; vaccines comprising polysaccharide antigens and protein-based antigens; vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens
NOT AVAILABLE"VACCINE"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, February 17, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAffinivax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, DE 19808
Party NameAffinivax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02420

Trademark Events

Event DateEvent Description
Tuesday, January 29, 2019NEW APPLICATION ENTERED
Sunday, February 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 8, 2019ASSIGNED TO EXAMINER
Tuesday, April 9, 2019NON-FINAL ACTION WRITTEN
Tuesday, April 9, 2019NON-FINAL ACTION E-MAILED
Tuesday, April 9, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 16, 2019ASSIGNED TO LIE
Friday, October 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 7, 2019FINAL REFUSAL WRITTEN
Thursday, November 7, 2019FINAL REFUSAL E-MAILED
Thursday, November 7, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, May 6, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, May 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 28, 2020SUSPENSION LETTER WRITTEN
Thursday, May 28, 2020LETTER OF SUSPENSION E-MAILED
Thursday, May 28, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, November 29, 2020ASSIGNED TO LIE
Monday, November 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 5, 2021PUBLISHED FOR OPPOSITION
Tuesday, January 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 23, 2021SOU TEAS EXTENSION RECEIVED
Monday, August 23, 2021SOU EXTENSION 1 FILED
Monday, August 23, 2021SOU EXTENSION 1 GRANTED
Wednesday, August 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 10, 2022SOU TEAS EXTENSION RECEIVED
Monday, January 10, 2022SOU EXTENSION 2 FILED
Monday, January 10, 2022SOU EXTENSION 2 GRANTED
Wednesday, January 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 28, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 28, 2022SOU EXTENSION 3 FILED
Thursday, July 28, 2022SOU EXTENSION 3 GRANTED
Saturday, July 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 21, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, October 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 21, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 21, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 22, 2023SOU EXTENSION 4 FILED
Wednesday, February 22, 2023SOU EXTENSION 4 GRANTED
Friday, February 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 31, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 31, 2023SOU EXTENSION 5 FILED
Monday, September 11, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 11, 2023SOU EXTENSION 5 GRANTED
Tuesday, September 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 22, 2023TEAS REQUEST TO DIVIDE RECEIVED
Friday, September 22, 2023DIVISIONAL REQUEST RECEIVED
Tuesday, October 3, 2023DIVISIONAL PROCESSING COMPLETE
Wednesday, October 4, 2023CORRECTED NOA E-MAILED
Monday, April 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, April 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

vaccine maps vaccines antigens based comprising polysaccharide immunotherapies protein namely treatment cancer